Page last updated: 2024-11-07

ungeremine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ungeremine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3738100
CHEMBL ID479291
CHEBI ID32277
PubMed CID159646
CHEMBL ID253553
SCHEMBL ID20741474
MeSH IDM0065989

Synonyms (35)

Synonym
CHEMBL479291
chebi:32277 ,
bdbm50358566
5,7-dioxa-12-azoniapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-1(18),2,4(8),9,11,15(19),16-heptaen-17-olate
72510-04-4
NCI60_002978
NCIMECH_000324
1,2,3,3a,6,7,12b,12c-octadehydro-2-hydroxylycoranium
4,5-dihydro-2-hydroxy-(1,3)dioxolo(4,5-j)pyrrolo(3.2.1-de)phenanthridinium
lycoranium, 1,2,3,3a,6,7,12b,12c-octadehydro-2-hydroxy-
4,5-dihydro-2-hydroxy-(1,3)dioxolo(4,5-j)pyrrolo(3,2,1-de)phenanthridinium
(1,3)dioxolo(4,5-j)pyrrolo(3,2,1-de)phenanthridinium, 4,5-dihydro-2-hydroxy-
lycobetaine
ungeremine
2121-12-2
CHEMBL253553
9evc5b2rps ,
unii-9evc5b2rps
CCG-35585
FT-0698899
DTXSID50175439
2121-12-2 (cl: 2121-16-6)
ungeremine (lycobetaine)
AKOS037515332
HY-N1971
FT-0701446
Q15633984
lycobetaineungeremine
5,7-dioxa-12-azoniapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-1(18),2,4(8),9,11,15(19),16-heptaen-17-ol
CS-0018291
SCHEMBL20741474
17-hydroxy-5,7-dioxa-12|e?-azapentacyclo[10.6.1.0?,??.0?,?.0??,??]nonadeca-1(18),2,4(8),9,11,15(19),16-heptaen-12-ylium
2-hydroxy-4h,5h-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridin-6-ium
[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridinium, 4,5-dihydro-2-hydroxy-
ungerimine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)IC50 (µMol)6.10000.02101.862610.0000AID632907
DNA topoisomerase 2-alphaHomo sapiens (human)IC50 (µMol)25.80000.48004.35649.9400AID632906
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)3.85000.00000.933210.0000AID311339
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (38)

Processvia Protein(s)Taxonomy
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
hematopoietic progenitor cell differentiationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topological changeDNA topoisomerase 2-alphaHomo sapiens (human)
DNA ligationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA damage responseDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome segregationDNA topoisomerase 2-alphaHomo sapiens (human)
female meiotic nuclear divisionDNA topoisomerase 2-alphaHomo sapiens (human)
apoptotic chromosome condensationDNA topoisomerase 2-alphaHomo sapiens (human)
embryonic cleavageDNA topoisomerase 2-alphaHomo sapiens (human)
regulation of circadian rhythmDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of apoptotic processDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediateDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIDNA topoisomerase 2-alphaHomo sapiens (human)
rhythmic processDNA topoisomerase 2-alphaHomo sapiens (human)
negative regulation of DNA duplex unwindingDNA topoisomerase 2-alphaHomo sapiens (human)
resolution of meiotic recombination intermediatesDNA topoisomerase 2-alphaHomo sapiens (human)
sister chromatid segregationDNA topoisomerase 2-alphaHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (28)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
magnesium ion bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
chromatin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
RNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA topoisomerase 2-alphaHomo sapiens (human)
protein kinase C bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP-dependent activity, acting on DNADNA topoisomerase 2-alphaHomo sapiens (human)
DNA binding, bendingDNA topoisomerase 2-alphaHomo sapiens (human)
protein homodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
ubiquitin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein heterodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (28)

Processvia Protein(s)Taxonomy
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
centrioleDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome, centromeric regionDNA topoisomerase 2-alphaHomo sapiens (human)
condensed chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
male germ cell nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
cytoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA topoisomerase 2-alphaHomo sapiens (human)
protein-containing complexDNA topoisomerase 2-alphaHomo sapiens (human)
ribonucleoprotein complexDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (66)

Assay IDTitleYearJournalArticle
AID1132122Toxicity in mouse allografted with mouse P388 cells assessed as change in body weight at 50 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1132115Antileukemic activity against mouse P388 cells allografted in mouse at 25 mg/kg administered daily as single dose relative to control1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID403385Cytotoxicity against human DU145 cells after 48 hrs by SRB assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID1366150Antibacterial activity against Flavobacterium columnare BioMed2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID438119Growth inhibition of proapoptotic stimuli-resistant human A549 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1366151Antibacterial activity against Pseudomonas aeruginosa2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID1578097Antitrypanosomal activity against Leishmania donovani2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID632907Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID491982Cytotoxicity against human SK-MEL cells after 72 hrs by MTT colorimetric assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
AID438124Growth inhibition of proapoptotic stimuli-sensitive human Hs683 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID491983Cytotoxicity against mouse B16F10 cells after 72 hrs by MTT colorimetric assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
AID632906Inhibition of human topoisomerase 2alpha-mediated relaxation of supercoiled pBR322 DNA2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID1366148Antibacterial activity against Escherichia coli2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID1132125Toxicity in mouse allografted with mouse P388 cells assessed as change in body weight at 3.13 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID491978Cytotoxicity against human A549 cells after 72 hrs by MTT colorimetric assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
AID632908Inhibition of Escherichia coli DNA topoisomerase 4-mediated relaxation of supercoiled pBR322 DNA2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID632916Antibacterial activity against Staphylococcus epidermidis by agar dilution method2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID403382Cytotoxicity against human SF268 cells after 48 hrs by SRB assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID438126Growth inhibition of proapoptotic stimuli-resistant human SK-MEL-28 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID311339Inhibition of AChE by Ellman method2007Journal of natural products, Sep, Volume: 70, Issue:9
Benzylphenethylamine alkaloids from Hosta plantaginea with inhibitory activity against tobacco mosaic virus and acetylcholinesterase.
AID632909Inhibition of Escherichia coli DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID1366147Antibacterial activity against Flavobacterium columnare BioMed after 24 hrs2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID491981Cytotoxicity against human U373 cells after 72 hrs by MTT colorimetric assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
AID1366145Antibacterial activity against Edwardsiella ictaluri after 24 hrs2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID1132111Antileukemic activity against mouse P388 cells allografted in mouse assessed as host survival at 6.25 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1132116Antileukemic activity against mouse P388 cells allografted in mouse at 12.5 mg/kg administered daily as single dose relative to control1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID438127Growth inhibition of proapoptotic stimuli-sensitive mouse B16F10 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID632910Binding affinity to calf thymus DNA assessed as change in absorption spectra at increasing concentration at pH 8 by UV-Vis spectra analysis2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID1366152Antibacterial activity against Staphylococcus aureus2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID632914Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID633057Antibacterial activity against Salmonella typhi by agar dilution method2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID1132109Antileukemic activity against mouse P388 cells allografted in mouse assessed as host survival at 25 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1366149Antibacterial activity against Flavobacterium columnare ALM-00-1732017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID1132108Antileukemic activity against mouse P388 cells allografted in mouse assessed as host survival at 50 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID403379Cytotoxicity against mouse P388 cells2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID1132110Antileukemic activity against mouse P388 cells allografted in mouse assessed as host survival at 12.5 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID632911Inhibition of human topoisomerase 2alpha kinetoplast DNA decatenation activity assessed as formation of monomeric circle from DNA at pH 8 after 1 hr2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID632915Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID491980Cytotoxicity against human Hs683 cells after 72 hrs by MTT colorimetric assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
AID1132114Antileukemic activity against mouse P388 cells allografted in mouse at 50 mg/kg administered daily as single dose relative to control1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1366144Antibacterial activity against Corynebacterium fascians assessed as diameter of inhibition zone at 10 mM after 48 to 72 hrs by paper disc method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID403383Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID1132123Toxicity in mouse allografted with mouse P388 cells assessed as change in body weight at 12.5 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1132121Toxicity in mouse allografted with mouse P388 cells assessed as change in body weight at 25 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID403380Cytotoxicity against human BxPC3 cells after 48 hrs by SRB assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID403381Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID491979Cytotoxicity against human OE21 cells after 72 hrs by MTT colorimetric assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
AID1132117Antileukemic activity against mouse P388 cells allografted in mouse at 6.25 mg/kg administered daily as single dose relative to control1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID632913Stabilization of Escherichia coli DNA topoisomerase 1-DNA cleavage complex assessed as cleavage enhancement using 32P-TAACCCTGAAAGATTATGCAATGCGCTTTGGG ssDNA as substrate at 10 to 200 uM at pH 8 after 20 mins by agarose gel electrophoresis relative to cont2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID632912Inhibition of Escherichia coli topoisomerase 4 kinetoplast DNA decatenation activity assessed as formation of monomeric circle from DNA at pH 8 after 1 hr2011Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
AID1578093Antitrypanosomal activity against Trypanosoma cruzi2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID403384Cytotoxicity against human KM20L2 cells after 48 hrs by SRB assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Antineoplastic agents. 553. The Texas grasshopper Brachystola magna.
AID1578098Antitrypanosomal activity against Trypanosoma brucei rhodesiense2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID438125Growth inhibition of proapoptotic stimuli-resistant human U373 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1366146Antibacterial activity against Flavobacterium columnare ALM-00-173 after 24 hrs2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID438120Growth inhibition of proapoptotic stimuli-resistant human OE21 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1132112Antileukemic activity against mouse P388 cells allografted in mouse assessed as host survival at 3.13 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1132124Toxicity in mouse allografted with mouse P388 cells assessed as change in body weight at 6.25 mg/kg administered daily as single dose1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID1132118Antileukemic activity against mouse P388 cells allografted in mouse at 3.13 mg/kg administered daily as single dose relative to control1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction.
AID725736Inhibition of topoisomerase 2alpha in human A431 cells assessed as DNA peak fractions level after 1 hr by ICE assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
AID725728Inhibition of human recombinant topoisomerase 2alpha-mediated decatenation of kDNA at 50 uM after 60 mins by ethidium bromide staining based gel electrophoresis analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
AID725735Inhibition of topoisomerase 2beta in human A431 cells assessed as DNA peak fractions level after 1 hr by ICE assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
AID725734Stabilization of topoisomerase 1/DNA complex in human A431 cells2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
AID725733Growth inhibition of human GXF251L cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
AID725730Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC18 plasmid DNA in human MCF7 cells nuclear extracts at 10 uM after 30 mins by ethidium bromide staining based gel electrophoresis analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
AID725723Inhibition of human recombinant topoisomerase 2beta-mediated decatenation of kDNA at 30 uM after 60 mins by ethidium bromide staining based gel electrophoresis analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (34.38)18.7374
1990's1 (3.13)18.2507
2000's6 (18.75)29.6817
2010's13 (40.63)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.66 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]